Source:Ministry of Defence: India

As part of Mission Sagar – IV, Indian Naval Ship Jalashwa arrived at Port Ehoala, Madagascar on 22 March 2021.

The ship will deliver a consignment of 1,000 Metric Tonne of rice and 100,000 Hydroxychloroquine tablets in response to an appeal made by Madagascar for assistance to deal with natural calamities.

An official ceremony for handing over the aid from the Government of India to Government of Madagascar was held on 23 March 2021. The ceremony was attended by H.E. Christian Ntsay, the Honb’le Prime Minister of Madagascar, Mr Jerry Hatrefindrazana, Governor of Anosy Region and Mr Georges MamyRandrianiaina, Mayor of Fort Dauphin.

The Indian side was represented by Mr Abhay Kumar, Ambassador of India to Madagascar and Captain Pankaj Chauhan, Commanding Officer INS Jalashwa.

This is the second visit of an Indian Navy ship to the island country within a span of one year. Earlier, as part of Mission Sagar-I, In May-June 2020, the Indian Navy had delivered essential medicines to the nation. INS Jalashwa’s visit is in keeping with India’s response to the disasters that have struck Madagascar in the past year.

The outreach by the Government of India aims to help Madagascar tide over the ongoing COVID-19 pandemic and severe drought that they have been facing. ‘Mission Sagar’ builds on the excellent relations existing between the two countries to battle the natural calamities and their resultant difficulties. The deployment also resonates with the vision of our Prime Minister of Security and Growth for All in the Region ‘SAGAR and highlights the importance accorded by India to relations with the countries in the IOR.

The operation is being progressed in close coordination with the Ministry of External Affairs, and other agencies of the Government of India.








Related:
Association of Italian Doctors successfully treats COVID patients with vitamin D and hydroxychloroquine

This doctor cured 5000 corona patients with hydroxychloroquine

Act early with early Covid-19 treatment: Dr Vladimir Zelenko

COVID-19 outpatients – early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study

The story behind hydroxychloroquine and the Zelenko Protocol: safe pre-hospital treatments for Covid

‘Only a one in 17 billion chance hydroxychloroquine doesn’t work’: medical professor

Top US medics recommend ‘sequenced multidrug therapy’ including HCQ & Ivermectin, for early high-risk COVID-19 infections

Epidemiologist At Yale Provides Testimony On Hydroxychloroquine For Treating COVID-19

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »